AbbVie Inc. Liabilities, Other than Long-term Debt, Noncurrent
AbbVie Inc. (ABBV) had Liabilities, Other than Long-term Debt, Noncurrent of $17.60 billion as of 2019-12-31, per its 10-K filed 2020-02-21.
Discontinued › Balance Sheet › Liabilities
us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent · last filed 2020-02-21
- 2019-12-31: Liabilities, Other than Long-term Debt, Noncurrent $17.60B.
- 2019-09-30: Liabilities, Other than Long-term Debt, Noncurrent $15.99B.
- 2019-06-30: Liabilities, Other than Long-term Debt, Noncurrent $16.00B.
- 2019-03-31: Liabilities, Other than Long-term Debt, Noncurrent $14.51B.
| Period end | Liabilities, Other than Long-term Debt, Noncurrent | Liabilities, Other than Long-term Debt, Noncurrent as first filed |
|---|---|---|
| 2019-12-31 | $17.60B 10-K · filed 2020-02-21 | |
| 2019-09-30 | $15.99B 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $16.00B 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $14.51B 10-Q · filed 2019-05-03 | |
| 2018-12-31 | $14.49B 10-K · filed 2020-02-21 | |
| 2018-09-30 | $15.72B 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $15.54B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $15.52B 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $15.61B 10-K · filed 2019-02-27 | |
| 2017-09-30 | $9.00B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $8.52B 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $8.50B 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $8.35B 10-K · filed 2018-02-16 | |
| 2016-09-30 | $7.65B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $7.79B 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $3.51B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $3.69B 10-K · filed 2017-02-17 | |
| 2015-09-30 | $3.80B 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $3.92B 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $3.59B 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $3.68B 10-K · filed 2016-02-19 | $3.84B 10-K · filed 2015-02-20 |
| 2014-09-30 | $2.71B 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $3.04B 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $3.36B 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $3.54B 10-K · filed 2015-02-20 | |
| 2013-09-30 | $3.42B 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $3.22B 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $2.85B 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $2.24B 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |